Eva Bleul
General Counsel chez CORETECH 5
Profil
Eva Bleul is currently working as a Director of Regulatory Affairs at Coretech 5 SA. Previously, she worked as a Director of Regulatory Affairs at Elanco Animal Health.
Before that, she was the Head of Regulatory Affairs at Elanco Tiergesundheit AG from 2002 to 2014.
Dr. Bleul holds a doctorate degree from the University of Giessen.
Postes actifs de Eva Bleul
| Sociétés | Poste | Début |
|---|---|---|
| CORETECH 5 | General Counsel | - |
Anciens postes connus de Eva Bleul
| Sociétés | Poste | Fin |
|---|---|---|
Elanco Tiergesundheit AG
 Elanco Tiergesundheit AG Pharmaceuticals: MajorHealth Technology Elanco Tiergesundheit AG manufactures animal vaccines. The firm provides pet health, livestock and Bioprotection products. The company's products include Atopica, Capstar, Deramaxx, Fortekor, Interceptor, Milbemax, Parc-tic and Sentinel. It is headquartered in Basel, Switzerland. | General Counsel | 01/01/2014 |
| Elanco Animal Health /Switzerland/ | General Counsel | - |
Formation de Eva Bleul
| University of Giessen | Doctorate Degree |
Expériences
Fonctions occupées
Relations
Relations au 1er degré
Entreprises liées au 1er degré
Homme
Femme
Administrateurs
Exécutifs
Sociétés liées
| Sociétés cotées | 1 |
|---|---|
| CORETECH 5 | Process Industries |
| Entreprise privées | 2 |
|---|---|
Elanco Tiergesundheit AG
Elanco Tiergesundheit AG Pharmaceuticals: MajorHealth Technology Elanco Tiergesundheit AG manufactures animal vaccines. The firm provides pet health, livestock and Bioprotection products. The company's products include Atopica, Capstar, Deramaxx, Fortekor, Interceptor, Milbemax, Parc-tic and Sentinel. It is headquartered in Basel, Switzerland. | Health Technology |
| Elanco Animal Health /Switzerland/ |
